RMC-4630
RMC-4630-02
Phase 2 small_molecule completed
Quick answer
RMC-4630 for Solid Tumor is a Phase 2 program (small_molecule) at Revolution Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Revolution Medicines
- Indication
- Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed